2.5M
XNAS Volume
High volume today
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 13,905 | 31,095 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.75 per share. | 18 Mar 2025 | 4,584 | 83,904 | - | 3.8 | 17,190 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. | 18 Mar 2025 | 13,905 | 97,809 | - | 1.3 | 17,937 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 Mar 2025 | 45,316 | 52,493 | - | 8.8 | 396,995 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 4,584 | 195,416 | - | - | Stock Option (Right to Buy) | |
| Paul Peter Tak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 18 Mar 2025 | 400 | 225,740 | - | 9.0 | 3,601 | Common Stock |
| Paul Peter Tak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.77 per share. | 18 Mar 2025 | 25,772 | 226,140 | - | 8.8 | 226,023 | Common Stock |
| Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 Mar 2025 | 32,146 | 96,527 | - | 8.8 | 281,673 | Common Stock |
| Francesca Barone | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.55 per share. | 18 Mar 2025 | 18,000 | 128,673 | - | 1.6 | 27,900 | Common Stock |
| Francesca Barone | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 18,000 | 30,822 | - | - | Stock Option (Right to Buy) | |
| Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.82 per share. | 17 Mar 2025 | 31,278 | 85,512 | - | 8.8 | 275,947 | Common Stock |
| Seshu Tyagarajan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 20,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 8.83 per share. | 17 Mar 2025 | 5,000 | 38,038 | - | 8.8 | 44,169 | Common Stock |
| Seshu Tyagarajan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 20,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.82 per share. | 17 Mar 2025 | 31,278 | 85,512 | - | 8.8 | 275,947 | Common Stock |
| Seshu Tyagarajan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. | 17 Mar 2025 | 20,000 | 116,790 | - | 1.3 | 25,800 | Common Stock |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 12.02 per share. | 21 Feb 2025 | 10,582 | 120,861 | - | 12.0 | 127,196 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 12.02 per share. | 21 Feb 2025 | 10,583 | 162,929 | - | 12.0 | 127,208 | CADL |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 107,250 | 107,250 | - | - | Stock Option (Right to Buy) | |
| Paul Peter Tak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) | |
| Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Seshu Tyagarajan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Charles Schoch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 83,000 | 83,000 | - | - | Stock Option (Right to Buy) | |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.61 per share. | 10 Feb 2025 | 31,335 | 60,000 | - | 8.6 | 269,794 | CADL |
| William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 10,428 | 79,320 | - | 7.2 | 75,342 | Common Stock |
| Paul Peter Tak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 21,704 | 251,912 | - | 7.2 | 156,811 | Common Stock |
| Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 13,534 | 110,673 | - | 7.2 | 97,783 | Common Stock |
| Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 14,322 | 96,790 | - | 7.2 | 103,476 | Common Stock |
| Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 7.23 per share. | 15 Jan 2025 | 9,511 | 43,038 | - | 7.2 | 68,717 | Common Stock |
| Aguilar-Cordova Estuardo | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.85 per share. | 26 Dec 2024 | 50,000 | 173,512 | - | 8.9 | 442,500 | CADL |
| Aguilar-Cordova Estuardo | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 9.01 per share. | 26 Dec 2024 | 50,000 | 223,512 | - | 9.0 | 450,500 | CADL |
| Aguilar-Cordova Estuardo | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.85 per share. | 26 Dec 2024 | 50,000 | 131,443 | - | 8.9 | 442,500 | CADL |
| Aguilar-Cordova Estuardo | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 9.01 per share. | 26 Dec 2024 | 50,000 | 181,443 | - | 9.0 | 450,500 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.82 per share. | 20 Dec 2024 | 50,000 | 231,443 | - | 8.8 | 441,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 9.00 per share. | 20 Dec 2024 | 100,000 | 373,512 | - | 9 | 900,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 9.00 per share. | 20 Dec 2024 | 100,000 | 331,443 | - | 9 | 900,000 | CADL |
| Aguilar-Cordova Estuardo | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.82 per share. | 20 Dec 2024 | 50,000 | 273,512 | - | 8.8 | 441,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.52 per share. | 20 Dec 2024 | 50,000 | 323,512 | - | 8.5 | 426,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.52 per share. | 20 Dec 2024 | 50,000 | 281,443 | - | 8.5 | 426,000 | CADL |
| Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 16 Dec 2024 | 500,000 | 1,142,406 | - | 6 | 3,000,000 | Common Stock |
| Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 16 Dec 2024 | 750,000 | 1,303,752 | - | 6 | 4,500,000 | Common Stock |
| Aguilar-Cordova Estuardo | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.53 per share. | 11 Dec 2024 | 200,000 | 631,443 | - | 8.5 | 1,706,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 10.04 per share. | 11 Dec 2024 | 200,000 | 473,512 | - | 10.0 | 2,008,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.53 per share. | 11 Dec 2024 | 200,000 | 673,512 | - | 8.5 | 1,706,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 10.04 per share. | 11 Dec 2024 | 200,000 | 431,443 | - | 10.0 | 2,008,000 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.23 per share. | 04 Dec 2024 | 20,000 | 91,335 | - | 5.2 | 104,600 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 4.46 per share. | 04 Dec 2024 | 20,000 | 131,335 | - | 4.5 | 89,200 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 4.79 per share. | 04 Dec 2024 | 20,000 | 111,335 | - | 4.8 | 95,800 | CADL |
| Tak Peter Paul | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 29 Nov 2024 | 48,847 | 294,788 | - | 4.6 | 222,527 | Common Stock |
| Tyagarajan Seshu | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 29 Nov 2024 | 20,392 | 125,657 | - | 4.6 | 92,898 | Common Stock |
| Garrett William Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 29 Nov 2024 | 13,935 | 100,547 | - | 4.6 | 63,482 | Common Stock |
| Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 29 Nov 2024 | 22,081 | 137,880 | - | 4.6 | 100,592 | Common Stock |
| Aguilar-Cordova Estuardo | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 4.97 per share. | 25 Nov 2024 | 20,000 | 151,335 | - | 5.0 | 99,400 | CADL |
| Paul Peter Tak | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2024 | 12,900 | 1,763,968 | - | - | Stock Option (Right to Buy) | |
| Paul Peter Tak | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.55 per share. | 21 Nov 2024 | 12,900 | 343,635 | - | 1.6 | 19,995 | Common Stock |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.33 per share. | 06 Nov 2024 | 7,500 | 888,512 | - | 5.3 | 39,975 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 4.92 per share. | 06 Nov 2024 | 7,500 | 831,443 | - | 4.9 | 36,900 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 4.92 per share. | 06 Nov 2024 | 7,500 | 873,512 | - | 4.9 | 36,900 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.19 per share. | 06 Nov 2024 | 7,500 | 838,943 | - | 5.2 | 38,925 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.19 per share. | 06 Nov 2024 | 7,500 | 881,012 | - | 5.2 | 38,925 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.33 per share. | 06 Nov 2024 | 7,500 | 846,443 | - | 5.3 | 39,975 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.27 per share. | 30 Oct 2024 | 7,500 | 853,943 | - | 5.3 | 39,525 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.27 per share. | 30 Oct 2024 | 7,500 | 896,012 | - | 5.3 | 39,525 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.30 per share. | 30 Oct 2024 | 7,500 | 861,443 | - | 5.3 | 39,750 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.30 per share. | 30 Oct 2024 | 7,500 | 903,512 | - | 5.3 | 39,750 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.38 per share. | 30 Oct 2024 | 6,000 | 868,943 | - | 5.4 | 32,280 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.38 per share. | 30 Oct 2024 | 6,000 | 911,012 | - | 5.4 | 32,280 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.53 per share. | 24 Oct 2024 | 16,427 | 903,034 | - | 5.5 | 90,841 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.58 per share. | 24 Oct 2024 | 11,711 | 888,532 | - | 5.6 | 65,347 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.80 per share. | 24 Oct 2024 | 1,597 | 900,243 | - | 5.8 | 9,263 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 5.72 per share. | 24 Oct 2024 | 1,194 | 901,840 | - | 5.7 | 6,830 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.02 per share. | 11 Oct 2024 | 15,000 | 929,873 | - | 6.0 | 90,300 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 11 Oct 2024 | 10,412 | 919,461 | - | 6.0 | 62,784 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.05 per share. | 11 Oct 2024 | 15,000 | 944,873 | - | 6.1 | 90,750 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 01 Oct 2024 | 6,214 | 988,661 | - | 7.0 | 43,555 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 01 Oct 2024 | 1,800 | 959,873 | - | 6.9 | 12,330 | CADL |
| Estuardo Aguilar-Cordova | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.92 per share. | 01 Oct 2024 | 26,988 | 961,673 | - | 6.9 | 186,757 | CADL |
| Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 14,051 | 159,961 | - | 6.5 | 90,947 | Common Stock |
| Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 9,884 | 62,520 | - | 6.5 | 63,975 | Common Stock |
| Tyagarajan Seshu | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 14,851 | 146,049 | - | 6.5 | 96,125 | Common Stock |
| Garrett Nichols William | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 10,875 | 114,482 | - | 6.5 | 70,390 | Common Stock |
| Tak Peter Paul | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 22,528 | 330,735 | - | 6.5 | 145,815 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 9,769 | 125,357 | - | 6.0 | 58,354 | Common Stock |
| Paul Peter Tak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 20,293 | 353,263 | - | 6.0 | 121,218 | Common Stock |
| Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 12,645 | 174,012 | - | 6.0 | 75,534 | Common Stock |
| Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 13,330 | 160,900 | - | 6.0 | 79,625 | Common Stock |
| Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 8,897 | 72,404 | - | 6.0 | 53,145 | Common Stock |
| Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Edward J. Benz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Renee M. Gaeta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Christopher Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Nicoletta Loggia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Edward J. Benz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Renee M. Gaeta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Estuardo Aguilar-Cordova | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Christopher Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Nicoletta Loggia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 28,480 | 28,480 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Paul Peter Tak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Biuy) | |
| Seshu Tyagarajan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Joseph C. Papa | Director | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 08 Dec 2022 | 35,018 | 38,032 | - | 1.9 | 67,935 | Common Stock |
| Joseph C. Papa | Director | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 08 Dec 2022 | 3,014 | 3,014 | - | 1.7 | 5,124 | Common Stock |
| Paul Peter Tak | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 08 Dec 2022 | 12,935 | 40,985 | - | 1.9 | 24,835 | Common Stock |
| Paul Peter Tak | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 08 Dec 2022 | 3,050 | 28,050 | - | 1.7 | 5,185 | Common Stock |
| Christopher Martell | Director | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 08 Dec 2022 | 23,950 | 152,000 | - | 1.9 | 45,984 | Common Stock |
| Christopher Martell | Director | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 08 Dec 2022 | 3,050 | 128,050 | - | 1.7 | 5,124 | Common Stock |
| Francesca Barone | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 08 Dec 2022 | 1,238 | 2,738 | - | 1.6 | 1,993 | Common Stock |
| Seshu Tyagarajan | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 08 Dec 2022 | 10,358 | 13,358 | - | 1.9 | 19,991 | Common Stock |
| Seshu Tyagarajan | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 08 Dec 2022 | 3,000 | 3,000 | - | 1.7 | 5,070 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 58,479 | 58,479 | - | 0 | Common Stock | |
| Paul Peter Tak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 195,906 | 220,906 | - | 0 | Common Stock | |
| Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 90,877 | 92,377 | - | 0 | Common Stock | |
| Seshu Tyagarajan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 73,684 | 73,684 | - | 0 | Common Stock | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Edward J. Benz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Estuardo Aguilar-Cordova | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Christopher Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 28,480 | 28,480 | - | - | Stock Option (Right to Buy) | |
| Renee M. Gaeta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 28,480 | 28,480 | - | - | Stock Option (Right to Buy) | |
| Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 28,480 | 28,480 | - | - | Stock Option (Right to Buy) | |
| Estuardo Aguilar-Cordova | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 76,717 | 0 | - | - | Stock Option (Right to Buy) | |
| Estuardo Aguilar-Cordova | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 12,205 | 0 | - | - | Stock Option (Right to Buy) | |
| Estuardo Aguilar-Cordova | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. | 06 May 2022 | 135,183 | 1,151,106 | - | 1.5 | 197,367 | Common Stock |
| Estuardo Aguilar-Cordova | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.65 per share. | 06 May 2022 | 54,074 | 1,097,032 | - | 3.6 | 197,370 | Common Stock |
| Estuardo Aguilar-Cordova | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 46,261 | 30,456 | - | - | Stock Option (Right to Buy) | |
| Laura K. Aguilar | Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.65 per share. | 06 May 2022 | 68,534 | 1,033,840 | - | 3.6 | 250,149 | Common Stock |
| Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 76,717 | 0 | - | - | Stock Option (Right to Buy) | |
| Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 76,717 | 0 | - | - | Stock Option (Right to Buy) | |
| Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 17,901 | 0 | - | - | Stock Option (Right to Buy) | |
| Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. | 06 May 2022 | 171,335 | 1,102,374 | - | 1.5 | 250,149 | Common Stock |
| Seshu Tyagarajan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Susan Stewart | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| John J. Canepa | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Paul Peter Tak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 330,000 | 330,000 | - | - | Stock Option (Right to Buy) | |
| Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 1,669,303 | 0 | - | - | Series B Preferred Stock | ||
| Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 679,158 | 679,158 | - | - | Common Stock | ||
| Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 1,361,069 | 0 | - | - | Series B Preferred Stock | ||
| Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 1,625,000 | 1,681,000 | - | 8 | 13,000,000 | Common Stock |
| Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 553,752 | 553,752 | - | - | Common Stock | ||
| John J. Canepa | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 10,125 | 10,125 | - | 8 | 81,000 | Common Stock |
| Diem Nguyen | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 10,000 | 10,000 | - | 8 | 80,000 | Common Stock |
| Nathan Caffo | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 6,000 | 6,000 | - | 8 | 48,000 | Common Stock |
| Paul Peter Tak | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 25,000 | 25,000 | - | 8 | 200,000 | Common Stock |
| Estuardo Aguilar-Cordova | Director, Chief Scientific Officer | 29 Jul 2021 | 398,519 | 0 | - | - | Series B Preferred Stock | ||
| Estuardo Aguilar-Cordova | Director, Chief Scientific Officer | 29 Jul 2021 | 162,137 | 1,015,923 | - | - | Common Stock | ||
| Laura K. Aguilar | Chief Medical Officer | 29 Jul 2021 | 56,096 | 931,039 | - | - | Common Stock | ||
| Laura K. Aguilar | Chief Medical Officer | 29 Jul 2021 | 137,881 | 0 | - | - | Series B Preferred Stock | ||
| Chris Martell | Director | 29 Jul 2021 | 696,851 | 0 | - | - | Series B Preferred Stock | ||
| Chris Martell | Director | 29 Jul 2021 | 283,514 | 283,514 | - | - | Common Stock | ||
| Chris Martell | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 125,000 | 125,000 | - | 8 | 1,000,000 | Common Stock |
| Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 7.36 per share. | 27 Jul 2021 | 36,000 | 36,000 | - | 7.4 | 264,834 | Common Stock |
| Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 7.30 per share. | 27 Jul 2021 | 20,000 | 56,000 | - | 7.3 | 145,944 | Common Stock |